Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-01-23
Adverse events
Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-02-21 (study day 30.0); relationship: PROBABLE
Mild INFLUENZA — outcome: RECOVERED/RESOLVED; onset 2013-06-07 (study day 136.0); relationship: NONE
Mild OEDEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-23 (study day 32.0); relationship: PROBABLE
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-23 (study day 60.0); relationship: PROBABLE
Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-23 (study day 60.0); relationship: PROBABLE
Data queries
No data queries.